Article Information
History
- September 13, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Massa Zantah, MD1,*,
- Eduardo Dominguez Castillo, MD1,
- Andrew J. Gangemi, MD1,
- Maulin Patel, MD1,
- Junad Chowdhury, MD1,
- Steven Verga, MD1,
- Osheen Abramian, MD1,
- Matthew Zheng, MD1,
- Kevin Lu, MD2,
- Arthur Lau, MD2,
- Justin Levinson, MD2,
- Hauquing Zhao, PhD, MS3,
- Gerard J. Criner, MD1,
- Roberto Caricchio, MD2,
- for the Temple University COVID-19 Research Group4
- 1Departments of Rheumatology, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140
- 2Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140
- 3Biostatistics at the Lewis Katz School of Medicine at Temple University, Philadelphia, PA 19140
- 4Temple University COVID-19 Research Group (names in supplementary file)
- ↵* Correspondence and reprint requests: Massa Zantah, MD Department of Thoracic Medicine and Surgery 745 Parkinson Pavilion Temple University Hospital 3401 North Broad Street Philadelphia PA 19140 Email: massa.zantah{at}tuhs.temple.edu Phone: 267-788-3828 Fax: 215-707-6867
Posted September 13, 2020.
Anakinra and Intravenous IgG versus Tocilizumab in the Treatment of COVID-19 Pneumonia
